TCW Group’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.2M	Sell	45,322 -29,732	-40%	-$788K	0.01%	294
2025 Q1	$1.81M	Buy	75,054 +13,403	+22%	+$324K	0.02%	261
2024 Q4	$2.48M	Buy	+61,651	New	+$2.48M	0.02%	241